Association Between Diffuse Myocardial Fibrosis by Cardiac Magnetic Resonance Contrast-Enhanced T 1 Mapping and Subclinical Myocardial Dysfunction in Diabetic Patients
Author(s) -
Arnold C.T. Ng,
Dominique Auger,
Victoria Delgado,
Saskia G. C. van Elderen,
Matteo Bertini,
Hans-Marc Siebelink,
Rob J. van der Geest,
Cosimo Bonetti,
Enno T. van der Velde,
Albert de Roos,
Johannes W. A. Smit,
Dominic Y. Leung,
Jeroen J. Bax,
Hildo J. Lamb
Publication year - 2011
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.111.965608
Subject(s) - medicine , cardiology , ejection fraction , myocardial fibrosis , diabetic cardiomyopathy , subclinical infection , diabetes mellitus , magnetic resonance imaging , body mass index , coronary artery disease , fibrosis , cardiac magnetic resonance imaging , heart failure , radiology , cardiomyopathy , endocrinology
Diabetic patients have increased interstitial myocardial fibrosis on histological examination. Magnetic resonance imaging (MRI) T(1) mapping is a previously validated imaging technique that can quantify the burden of global and regional interstitial fibrosis. However, the association between MRI T(1) mapping and subtle left ventricular (LV) dysfunction in diabetic patients is unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom